Genmab A/S Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | $1.19 | $1.41 | $1.29 |
Q2 2024 | 1 | $1.99 | $2.35 | $2.16 |
Q3 2024 | 4 | $1.72 | $2.40 | $2.13 |
Q4 2024 | 1 | $1.96 | $2.32 | $2.13 |
Q1 2025 | 2 | $1.48 | $1.76 | $1.61 |
Q2 2025 | 2 | $1.77 | $2.10 | $1.92 |
Q3 2025 | 2 | $2.46 | $2.91 | $2.67 |
Q4 2025 | 2 | $2.70 | $3.20 | $2.93 |
Q1 2026 | 1 | $2.81 | $3.33 | $3.05 |
Q2 2026 | 1 | $3.99 | $4.72 | $4.33 |
Q3 2026 | 1 | $4.32 | $5.11 | $4.69 |
Q4 2026 | 1 | $4.80 | $5.69 | $5.22 |
Genmab A/S Earnings Date And Information
Genmab A/S last posted its earnings results on Thursday, August 8th, 2024. The company reported $0.22 earnings per share for the quarter, missing analysts' consensus estimates of $0.29 by $0.07. The company had revenue of 5.40 B for the quarter and had revenue of 16.47 B for the year. Genmab A/S has generated $7 earnings per share over the last year ($6.6 diluted earnings per share) and currently has a price-to-earnings ratio of 19.03. Genmab A/S has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Genmab A/S Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
05/02/2024 | Q2 2024 | $0.16 | $2.19 | 2.03 | $5.08 B | $5.40 B |
05/02/2024 | Q1 2024 | $0.16 | $2.03 | 1.87 | $4.14 B | |
02/14/2024 | Q4 2023 | $0.34 | $0.98 | 0.64 | $4.68 B | |
11/07/2023 | Q3 2023 | $0.34 | $3.26 | 2.92 | $4.55 B | $4.74 B |
05/10/2023 | Q2 2023 | $0.09 | $2.08 | 1.99 | $4.10 B | $4.20 B |
05/10/2023 | Q1 2023 | $0.09 | $0.32 | 0.23 | $2.85 B | |
02/22/2023 | Q4 2022 | $0.90 | $5.23 B | |||
11/09/2022 | Q3 2022 | $1.65 | $3.96 | 2.31 | $3.61 B | $4.09 B |
05/11/2022 | Q2 2022 | $0.10 | $2.89 | 2.79 | $2.93 B | $3.16 B |
05/11/2022 | Q1 2022 | $0.10 | $0.71 | 0.61 | $300.49 M | $2.12 B |
11/10/2021 | Q4 2021 | $0.11 | $1.10 | 0.99 | $389.00 M | $2.62 B |
11/10/2021 | Q3 2021 | $0.11 | $1.36 | 1.25 | $339.46 M | $2.31 B |
05/05/2021 | Q2 2021 | $2.47 | $0.47 | -2 | $270.57 M | $1.97 B |
05/05/2021 | Q1 2021 | $2.47 | $1.68 | -0.79 | $220.61 M | $1.58 B |
11/04/2020 | Q4 2020 | $0.08 | $0.88 | 0.8 | $292.26 M | $2.04 B |
11/04/2020 | Q3 2020 | $0.08 | $0.81 | 0.73 | $237.70 M | $1.72 B |
05/06/2020 | Q2 2020 | $0.06 | $5.19 | 5.13 | $864.17 M | $5.45 B |
02/19/2020 | Q1 2020 | $0.41 | $131.08 M | $892.00 M | ||
11/06/2019 | Q4 2019 | $0.08 | $2.33 | 2.25 | $397.13 M | $2.96 B |
11/06/2019 | Q3 2019 | $0.08 | $0.84 | 0.76 | $136.73 M | $1.04 B |
Genmab A/S Earnings: Frequently Asked Questions
-
When is Genmab A/S's earnings date?
Genmab A/S has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Genmab A/S's earnings conference call?
The conference call for Genmab A/S's latest earnings report can be listened to online.
-
How can I read Genmab A/S's conference call transcript?
The conference call transcript for Genmab A/S's latest earnings report can be read online.
-
How much revenue does Genmab A/S generate each year?
Genmab A/S (:GMAB) has a recorded annual revenue of $16.47 B.
-
How much profit does Genmab A/S generate each year?
Genmab A/S (:GMAB) has a recorded net income of $16.47 B. Genmab A/S has generated $6.66 earnings per share over the last four quarters.
-
What is Genmab A/S's price-to-earnings ratio?
Genmab A/S (:GMAB) has a price-to-earnings ratio of 19.03 and price/earnings-to-growth ratio is 0.48.